Toronto Dominion Bank
BBC icon

Toronto Dominion Bank’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Toronto Dominion Bank’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$175K – 1821
2025
Q1 		$175K Buy
+10,000
New +$215K ﹤0.01% 1267

Other funds holding BBC

MCP
Militia Capital Partners Las Vegas, Nevada $263M AUM 65.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
DWS
Dynamic Wealth Strategies Granite Bay, California $173M AUM 14.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Toronto Dominion Bank's BBC Position: Q2 2025 in Review

Toronto Dominion Bank sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2025, closing a stake of 10,000 shares — an estimated $175K sold.

Toronto Dominion Bank first reported a position in BBC in Q1 2025 and held it in 1 quarter. The position peaked at $175K in Q1 2025. 11 funds tracked by Wall St. Rank hold BBC as of Q2 2025.

  • Toronto Dominion Bank reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 10,000 Virtus Biotech Clinical Trials ETF shares in Q2 2025, an estimated $175K.
  • Toronto Dominion Bank first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2025 and held it in 1 quarter.
  • Toronto Dominion Bank's Virtus Biotech Clinical Trials ETF position peaked at $175K in Q1 2025.
  • 11 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2025.

Based on Toronto Dominion Bank's 13F filing for Q2 2025, filed 14 Aug 2025.